ELN — Elanix Biotechnologies AG Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- €0.43m
- €0.39m
- €0.06m
Annual cashflow statement for Elanix Biotechnologies AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2014 December 31st | R2015 December 31st | C2016 December 31st | 2017 December 31st | 2018 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | GAS | IFRS | — | — | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.015 | — | — | — | — |
| Non-Cash Items | -0.02 | — | — | — | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.005 | -0.53 | -0.824 | -3.77 | -2.55 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.029 | -0.53 | -0.824 | -3.77 | -2.55 |
| Capital Expenditures | — | 0 | -0.019 | -0.035 | -0.003 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | -0.003 | -0.112 | 0 | 0 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | -0.003 | -0.131 | -0.035 | -0.003 |
| Financing Cash Flow Items | — | — | -0.259 | -0.479 | -0.62 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.05 | 0.582 | 0.956 | 3.95 | 2.37 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.02 | 0.049 | 0.001 | 0.139 | -0.192 |